Stryker ROE 2010-2025 | SYK

Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Stryker ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $2.86B $20.93B 14.04%
2024-12-31 $2.99B $20.63B 15.02%
2024-09-30 $3.59B $20.15B 18.49%
2024-06-30 $3.45B $19.76B 18.28%
2024-03-31 $3.36B $19.17B 18.41%
2023-12-31 $3.17B $18.59B 17.89%
2023-09-30 $2.59B $17.91B 15.03%
2023-06-30 $2.71B $17.36B 16.09%
2023-03-31 $2.63B $16.90B 16.01%
2022-12-31 $2.36B $16.62B 14.78%
2022-09-30 $2.46B $16.46B 15.84%
2022-06-30 $2.08B $15.67B 13.91%
2022-03-31 $2.02B $15.05B 13.92%
2021-12-31 $1.99B $14.88B 14.15%
2021-09-30 $1.90B $14.18B 13.92%
2021-06-30 $2.08B $13.82B 15.61%
2021-03-31 $1.41B $13.50B 10.76%
2020-12-31 $1.60B $13.08B 12.31%
2020-09-30 $1.76B $12.99B 13.60%
2020-06-30 $1.60B $12.75B 12.56%
2020-03-31 $2.16B $13.12B 17.25%
2019-12-31 $2.08B $12.81B 17.09%
2019-09-30 $3.43B $12.32B 28.74%
2019-06-30 $3.55B $11.94B 31.40%
2019-03-31 $3.52B $11.69B 32.96%
2018-12-31 $3.55B $11.73B 35.29%
2018-09-30 $1.24B $9.86B 12.83%
2018-06-30 $1.08B $9.46B 11.05%
2018-03-31 $1.02B $9.22B 10.28%
2017-12-31 $1.02B $9.98B 10.16%
2017-09-30 $1.78B $10.43B 17.92%
2017-06-30 $1.70B $10.04B 17.61%
2017-03-31 $1.69B $9.70B 17.93%
2016-12-31 $1.65B $9.55B 17.91%
2016-09-30 $1.66B $9.33B 18.56%
2016-06-30 $1.61B $9.10B 18.39%
2016-03-31 $1.62B $8.81B 18.85%
2015-12-31 $1.44B $8.51B 17.02%
2015-09-30 $1.18B $8.48B 13.89%
2015-06-30 $0.93B $8.51B 10.96%
2015-03-31 $0.67B $8.32B 7.75%
2014-12-31 $0.52B $8.60B 5.84%
2014-09-30 $0.64B $8.62B 7.17%
2014-06-30 $0.69B $9.00B 7.67%
2014-03-31 $0.77B $9.06B 8.71%
2013-12-31 $1.01B $9.05B 11.55%
2013-09-30 $0.89B $8.74B 10.35%
2013-06-30 $1.14B $8.60B 13.41%
2013-03-31 $1.25B $8.46B 15.01%
2012-12-31 $1.30B $8.60B 15.77%
2012-09-30 $1.43B $8.36B 17.85%
2012-06-30 $1.40B $7.95B 17.98%
2012-03-31 $1.39B $8.02B 17.89%
2011-12-31 $1.35B $7.68B 17.66%
2011-09-30 $1.24B $7.56B 16.54%
2011-06-30 $1.25B $7.78B 16.82%
2011-03-31 $1.26B $7.45B 17.55%
2010-12-31 $1.27B $7.17B 18.25%
2010-09-30 $1.28B $7.31B 18.80%
2010-06-30 $1.18B $6.75B 17.78%
2010-03-31 $1.15B $6.67B 17.82%
2009-12-31 $1.11B $6.60B 17.91%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $144.011B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.04
Boston Scientific (BSX) United States $147.560B 37.59
EssilorLuxottica (ESLOY) France $128.708B 0.00
Medtronic (MDT) Ireland $111.928B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.49
ResMed (RMD) United States $36.560B 27.72
Agilent Technologies (A) United States $33.258B 22.04
GE HealthCare Technologies (GEHC) United States $33.082B 15.84
Terumo (TRUMY) Japan $26.680B 34.37
Insulet (PODD) United States $21.438B 84.69
Koninklijke Philips (PHG) Netherlands $21.384B 15.43
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.71
Baxter (BAX) United States $15.713B 11.81
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.94
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.47
Perrigo (PRGO) Ireland $3.664B 9.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.31
ICU Medical (ICUI) United States $3.250B 24.18
Envista Holdings (NVST) United States $3.127B 26.73
GN Store Nord (GNNDY) Denmark $2.263B 19.32
QuidelOrtho (QDEL) United States $1.954B 13.59
LeMaitre Vascular (LMAT) United States $1.833B 41.46
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.67
AdaptHealth (AHCO) United States $1.161B 11.81
Green Thumb Industries (GTBIF) United States $1.048B 23.71
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.80
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.55
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 5.08
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.53
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 61.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.50
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.63
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 6.12
Brainsway (BWAY) Israel $0.206B 55.30
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 15.33
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.37
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 48.64
United-Guardian (UG) United States $0.037B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00